Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AXIM Biotechnologies Inc (AXIM)
OTHER OTC:AXIM
Holding AXIM?
Track your performance easily
AXIM Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.02
Previous Close$0.01
Volume891.42K
Average Volume (3M)N/A
Market Cap
$543.53K
Enterprise Value$5.77M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$5.22M
Price to Earnings (P/E)―
Beta-1.20
Next Earnings
Mar 19, 2018EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding301,958,824
10 Day Avg. Volume1,941,939
30 Day Avg. VolumeN/A
Standard Deviation0.46
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-0.06
Price to Sales (P/S)5.87
Price to Cash Flow (P/CF)0.30
P/FCF Ratio0.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue62.26
Enterprise Value/Gross Profit145.96
Enterprise Value/Ebitda-1.36
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
AXIM Biotechnologies News
PremiumCompany Announcements
AXIM Biotechnologies Resolves Dispute, Issues EquityOptions Prices
Currently, No data available
---
Ownership Overview
AXIM FAQ
What was AXIM Biotechnologies Inc’s price range in the past 12 months?
AXIM Biotechnologies Inc lowest stock price was <$0.01 and its highest was $0.02 in the past 12 months.
What is AXIM Biotechnologies Inc’s market cap?
Currently, no data Available
When is AXIM Biotechnologies Inc’s upcoming earnings report date?
AXIM Biotechnologies Inc’s upcoming earnings report date is Mar 19, 2018 which is 2470 days ago.
How were AXIM Biotechnologies Inc’s earnings last quarter?
AXIM Biotechnologies Inc released its earnings results on Aug 22, 2017. The company reported -$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.01.
Is AXIM Biotechnologies Inc overvalued?
According to Wall Street analysts AXIM Biotechnologies Inc’s price is currently Overvalued.
Does AXIM Biotechnologies Inc pay dividends?
AXIM Biotechnologies Inc does not currently pay dividends.
What is AXIM Biotechnologies Inc’s EPS estimate?
AXIM Biotechnologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AXIM Biotechnologies Inc have?
AXIM Biotechnologies Inc has 301,958,830 shares outstanding.
What happened to AXIM Biotechnologies Inc’s price movement after its last earnings report?
AXIM Biotechnologies Inc reported an EPS of -$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of AXIM Biotechnologies Inc?
Currently, no hedge funds are holding shares in AXIM
---
AXIM Biotechnologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-11.11%
Trailing 12-Months
Company Description
AXIM Biotechnologies Inc
AXIM Biotechnologies, Inc. is engaged in the research, development, and production of pharmaceutical, nutraceutical, cosmetic, and genetically controlled botanical products. It also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand; and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in New York, NY.
---
China Pharma Holdings
―
Citius Pharmaceuticals
―
Relmada Therapeutics
―
Sunshine Biopharma
―
---